ToughBuilt Industries, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Nature of Operations (Details Narrative)

Nature of Operations (Details Narrative) - USD ($)										12 Months Ended
Nature of Operations (Details Narrative) - USD ($)	Feb. 24, 2020	Jan. 28, 2020	Aug. 19, 2019	Apr. 11, 2019	Jan. 24, 2019	Dec. 17, 2018	Nov. 14, 2018	Sep. 04, 2018	Jun. 19, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 23, 2019	Dec. 21, 2019
Common stock, par value										$ 0.0001	$ 0.0001
Warrants to purchase common stock											3,070,500
Anti-dilution shares embedded										25,159,053	1,007,734
Proceeds from promissory note								$ 652,579	$ 100,000	$ 4,815,000	$ 752,579
Percentage for original issue discount									14.00%
Debt instrument face amount									$ 114,000
Payment of promissory note											$ 114,000
Preferred stock, shares authorized										5,000,000	5,000,000
Preferred stock, par value										$ 0.0001	$ 0.0001
Stock issued during the period, value											$ 8,014,228
Accumulated deficit										$ (43,413,370)	(39,112,401)
Net loss										(4,300,969)	(27,651,412)
Net cash used in operating activities										$ (10,229,337)	$ (8,243,415)
Investor [Member]
Warrants price per share			$ 1.00
Investor [Member] \| Series A Note [Member]
Debt instrument face amount			$ 6,720,000
Payment of promissory note			$ 5,000,000
Investor [Member] \| Notes [Member]
Percentage for original issue discount			15.00%
Debt instrument face amount			$ 4,780,000
Series D Preferred Stock [Member]
Initial public offering, shares
Preferred stock, shares authorized										5,775	0
Preferred stock, par value										$ 1,000	$ 1,000
Stock issued during the period, value
Net loss
Series D Preferred Stock [Member] \| Board of Directors [Member]
Preferred stock, shares authorized													5,775
Investors [Member] \| Series C Convertible Preferred Stock [Member]
Conversion of common stock				4,268,000
Conversion of stock, description				The shares of Series C Convertible Preferred Stock are convertible into 4,268,000 shares of the Company's common stock, and rights to convert into common stock are subject to limitations on ownership at any one time of Company common stock up to 9.9% of the issued and outstanding shares of common stock of the Company; otherwise, the Series C Convertible Preferred Stock has no rights not awarded to holders of common stock of the Company.
Securities Purchase Agreement [Member] \| Institutional Investor [Member]
Proceeds from promissory note			$ 11,500,000
Percentage for original issue discount			15.00%
Description for market capitalization			The Investor Note is subject to optional prepayment at any time at the option of the investor and mandatory prepayment, at the Company's option, subject to certain equity conditions, at any time 45 Trading Days after the effectiveness of a resale registration statement (or otherwise the applicability of Rule 144 promulgated under the Securities Act of 1933, as amended). Notwithstanding the foregoing, the Company may not effect a mandatory prepayment if the shares underlying the Series A Note and the portion of the Series B Note that has become unrestricted exceeds 35% of the market capitalization of the Company.
Exchange Agreement [Member] \| Investor [Member]
Debt instrument face amount												$ 5,500,000
Over-Allotment Option [Member] \| Underwriting Agreement [Member]
Common stock, par value						$ 0.0001
Option to purchase shares of common stock						25,000
Exercise price per share						$ 4.98
Proceeds from over allotment options						$ 121,909
Commission and expenses						$ 10,601
Public Offering [Member] \| Subsequent Event [Member]
Initial public offering, shares	4,450,000	23,725,000
Proceeds from initial public offering	$ 934,500
Stock issued during the period, value	$ 934,500	$ 9,030,000
Class A Units [Member] \| IPO [Member]
Initial public offering, shares							2,670,000
Common stock, par value							$ 0.0001
Warrants price per share							$ 5.00
Proceeds from initial public offering							$ 12,415,500
Underwriting discounts and commission							934,500
Stock issuance cost							$ 743,765
Series A Warrant [Member]
Warrants to purchase common stock							1
Series B Warrant [Member]
Warrants to purchase common stock							1
Series A Warrants [Member] \| Investors [Member]
Warrants to purchase common stock				1,189,560	508,940
Conversion of common stock					508,940
Series A Warrants [Member] \| Underwriting Agreement [Member]
Warrants to purchase common stock						400,500
Warrants price per share						$ 0.01
Series A Warrants [Member] \| Exchange Agreements [Member]
Warrants to purchase common stock					424,116
Stock issuance cost					$ 159,958
Gross proceeds of warrant					$ 2,172,680
Series A Warrants [Member] \| IPO [Member]
Warrants price per share							$ 215,625
Conversion of common stock							1,366,768
Series B Warrants [Member] \| Investors [Member]
Warrants to purchase common stock				1,005,760
Anti-dilution shares embedded				4,268
Series B Warrants [Member] \| Underwriting Agreement [Member]
Warrants to purchase common stock						400,500
Warrants price per share						$ 0.01
Series B Warrants [Member] \| IPO [Member]
Warrants price per share							$ 215,625
Conversion of common stock							1,366,768
New Warrants [Member] \| Investors [Member]
Warrants to purchase common stock					933,056
Warrants price per share					$ 3.67
Common Stock [Member]
Initial public offering, shares											2,670,000
Stock issued during the period, value											$ 267
Net loss
Common Stock [Member] \| Public Offering [Member] \| Subsequent Event [Member]
Initial public offering, shares		43,000,000
Warrant [Member] \| Public Offering [Member] \| Subsequent Event [Member]
Initial public offering, shares		47,450,000